JW Pharmaceutical releases new impotence drug

Published: 2011-10-21 07:00:00

Updated: 2011-10-21 07:00:00

JW Pharmaceutical said Wednesday that it has launched Zepeed (avanafil), a new medication for the treatment of erectile dysfunction (ED).

Zepeed is a next-generation, highly selective oral phosphodiesterase type 5 (PDE5) inhibitor therapy. The drug is Korea’s 17th homegrown erectile dysfunctio...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK